ONYX PHARMACEUTICALS
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.
ONYX PHARMACEUTICALS
Industry:
Biotechnology Medical
Founded:
1992-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.onyx-pharm.com
Total Employee:
101+
Status:
Closed
Contact:
(650) 266-0000
Total Funding:
20 M USD
Technology used in webpage:
LetsEncrypt WordPress Wordpress Plugins IPv6 Contact Form 7 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Lorem Ipsum
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-10-12 | Proteolix | Proteolix acquired by Onyx Pharmaceuticals | N/A |
Investors List
OrbiMed
OrbiMed investment in Venture Round - Onyx Pharmaceuticals
Perceptive Life Sciences
Perceptive Life Sciences investment in Venture Round - Onyx Pharmaceuticals
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Venture Round - Onyx Pharmaceuticals
Domain Associates
Domain Associates investment in Venture Round - Onyx Pharmaceuticals
Sequoia Capital
Sequoia Capital investment in Seed Round - Onyx Pharmaceuticals
